BDH INDUSTRIES LTD.
Healthcare › Pharmaceuticals & Biotechnology
₹487.90
at close · 21 Sept 2026
Latest filings
- Notice on special window for physical share dematerialisation · Compliance
- BDH Industries Q1 FY27 results: profit up 49% YoY · Compliance
- Board meeting on 14 Aug 2026 to consider Q1 FY27 results · Results
- Notice of 36th AGM along with dividend and e-voting details · Compliance
- BDH Industries fixes 7 Aug 2026 as record date for Rs 5 dividend · Corporate Actions
- BDH Industries submits FY26 Annual Report; 36th AGM on 14 August 2026 · Board & Shareholder Meetings
- BDH Industries 36th AGM on 14 Aug 2026, Rs 5 dividend recommended · Board & Shareholder Meetings
- Notice to shareholders on transfer of unclaimed shares to IEPF · Compliance
- BDH Industries 36th AGM notice and shareholder KYC update · Compliance
- CRISIL reaffirms BBB-/Stable and A3 ratings on Rs 40 Cr bank facilities · Credit & Debt
- Quarterly compliance certificate under SEBI Regulation 74(5) for Q1 FY27 · Compliance
- Special window for physical share transfer and dematerialization · Compliance
- Trading Window Closure Ahead of Q1 FY27 Results · Compliance
- Pursuant to regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended kindly find the attached herewith the Annual Secretarial Compliance Report .... · Compliance
- We are enclosing herewith the Audited Standalone Financial Results for the quarter and year ended on 31st March 2026 of the financial year 2025-26 published in todays newspapers - Free .... · Compliance
- Kindly find the enclosed herewith the meeting updates of the Board of Directors meeting held today under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations .... · Results
- The Board of Directors of the Company at their meeting held today have recommended a dividend of Rs. 5/- per equity share of face value Rs. 10/- each for the year ended on 31st March 2026 .... · Results
- Kindly find the enclosed herewith the Audited Standalone Financial Results for the fourth quarter and year ended on 31st March 2026 of the financial year 2025-26 as approved by the Board .... · Results
- The Board of Directors of the Company at their meeting held today have approved the Audited Standalone Financial Results for the fourth quarter and year ended on 31st March 2026 of the .... · Results
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith a copy of letter sent to shareholders holding equity .... · Compliance
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 13, 2026 for Ms. Purnima Hingorani · Ownership Changes
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 13, 2026 for Ms. Purnima Hingorani · Ownership Changes
- BDH Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the Audited Standalone Financial .... · Results
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 24, 2026 for Purnima Hingorani · Ownership Changes
- Special window for share transfer and dematerialisation (Feb 2026 – Feb 2027) · Compliance
- SAST disclosure received from Purnima Hingorani · Ownership Changes
- Initial Disclosure by Large Corporate Entity · Compliance
- Reg 74(5) Depository Compliance Certificate filed for Q4 FY26 · Compliance
- Intimation of Closure of Trading Window · Compliance
- Kindly find the enclosed herewith the Notice of special window opened for a period of one year from 5th February 2026 to 4th February 2027 to facilitate transfer and dematerialisation of .... · Compliance
- Kindly find the enclosed herewith the Standalone Unaudited Financial Results of the Company for the third quarter and nine months ended on 31st December 2025 of the financial year 2025-26 .... · Compliance
- The Board of Directors of the Company at their meeting held today approved the Standalone Unaudited Financial Results of the Company for the third quarter and nine months ended on 31st .... · Results
- The Board of Directors of the Company at their meeting held today approved the Standalone Unaudited Financial Results of the Company for the third quarter and nine months ended on31st December .... · Results
- BDH Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve the Standalone Unaudited Financial .... · Results
- Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December 2025 is enclosed herewith for reference. · Compliance
- Intimation of Closure of Trading Window · Compliance
- Kindly find the enclosed herewith the Notice of special window for re-lodgement of transfer requests of physical shares published in newspapers - Free Press Journal (in English language) .... · Compliance
- Kindly find the enclosed herewith the Standalone Unaudited Financial Results of the Company for the second quarter and half year ended on 30th September 2025 of the financial year 2025-26 .... · Compliance
- The Board of Directors of the Company at the meeting held today approved the Standalone Unaudited Financial Results for the second quarter and half year ended on 30th September 2025 of .... · Results
- The Board of Directors of the Company at the meeting held today approved the Standalone Unaudited Financial Results of the Company for the second quarter and half year ended on 30th September .... · Results
- BDH Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve the Standalone Unaudited Financial .... · Results
- Kindly find the enclosed herewith the Notice of special window for re-lodgement of transfer requests of physical shares published in todays newspapers - Free Press Journal (in English language) .... · Compliance
- Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30th September 2025 is enclosed herewith for reference. · Compliance
- Intimation of closure of trading window · Compliance
- Kindly note the enclosed herewith the information about the CRISIL ratings for the financial facilities of the Company. · Credit & Debt
- Kindly find the enclosed herewith the Notice of special window for re-lodgement of transfer request of physical shares published in todays newspapers - Free Press Journal ( in English language) .... · Compliance
- Kindly find the enclosed herewith the Standalone Unaudited Financial Results for the quarter ended on 30th June 2025 of the financial year 2025-26 published in newspapers - Free Press Journal .... · Compliance
- Kindly find the enclosed herewith the voting results of the 35th Annual General Meeting of the Company alongwith Consolidated Scrutinizers Report. · Board & Shareholder Meetings
- The proceedings of the 35th Annual General Meeting of the Company held on Friday, 8th August 2025 through VC/ OVAM are enclosed herewith for reference. · Board & Shareholder Meetings
- The Board of Directors of the Company have approved the Standalone Unaudited Financial Results for the quarter ended on 30th June 2025 of the financial year 2025-26. · Results
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹100 Cr over the trailing twelve months.
Market Cap
₹281 Cr
P / E (TTM)
24.0×
EV / EBITDA
14.6×
Div Yield
0.92%
Growth
10.8%▲
Revenue 5y CAGR
PAT +11.2% · EBITDA +10.4%
Quality
19.8%▲
ROCE (5y median)
ROE 14.9% · margin 16.8%
Leverage
0.03·
Debt / Equity · low
Net debt ₹-27 Cr
Revenue FY21→FY26
1.7×▲
Margin +0.2 pts
₹57 Cr → ₹96 Cr
Cash conversion
0.44×▼
Operating cash ÷ profit · 5 yrs
₹20 Cr on ₹45 Cr
Moves on a normal day
1.64%·
Median daily move
Last 268 sessions · filing days run larger
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#71/170
P/B#93/164
ROCE#38/183
ROE#55/171
Debt / Equity#60/171
EBITDA margin#83/165
Revenue growth#67/161
Profit growth#65/158
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Returns on capital 19.8% (5-year median)
#38 of 183 in Pharmaceuticals on the latest reported figures
Debt at 0.03× equity
lower than 65% of its 171 Pharmaceuticals peers
Pays out 24% of profit as dividend
Concerns
Over 5 years it reported ₹45 Cr of profit and ₹20 Cr of operating cash — 0.44×
Less than 60p of every ₹1 of profit arrived as cash
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from BDH INDUSTRIES LTD.'s filed financials and exchange disclosures
What does BDH INDUSTRIES LTD. do?
BDH INDUSTRIES LTD. is a Pharmaceuticals & Biotechnology company listed on BSE.
Is BDH INDUSTRIES LTD. profitable?
Yes. Over the trailing twelve months BDH INDUSTRIES LTD. reported a net profit of ₹12 Cr on revenue of ₹100 Cr.
Does BDH INDUSTRIES LTD. pay a dividend?
Yes. The dividend yield is 0.92% at the current price. It paid out 24% of its profit as dividend in FY26.
Is BDH INDUSTRIES LTD. debt-free?
Effectively yes. It holds ₹27 Cr more cash than debt. Debt stands at 0.03× equity.
Is BDH INDUSTRIES LTD. expensive compared with its peers?
On trailing P/E, BDH INDUSTRIES LTD. ranks 71 of 170 in Pharmaceuticals — cheaper than 58% of them, against an industry median of 29.6×. This is a position, not a valuation judgement.
How much does the BDH INDUSTRIES LTD. share price move in a day?
On a typical session BDH INDUSTRIES LTD. moves 1.64% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.
Where can I track BDH INDUSTRIES LTD.'s announcements?
Every NSE and BSE filing by BDH INDUSTRIES LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.